JNCE stock pitch - 2023-03-19

Added to YB: 2023-03-19

Pitch date: 2023-03-19

Jounce Therapeutics, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer.

Market Cap

$99.0M

Pitch Price

$1.65

Price Target

N/A

Dividend

N/A

EV/EBITDA

1.95

P/E

-1.91

EV/Sales

-0.98

Sector

Biotechnology

A summary for this pitch has not been created yet.